LifeStance Health Group, Inc. (LFST) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 225.94M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $225.94M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $194.80M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $248.64M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $203.90M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $188.93M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $134.34M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $154.57M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $102.61M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $86.97M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $49.45M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $78.82M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $42.60M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $79.61M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $68.29M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $108.62M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $90.34M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $96.69M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $113.99M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $148.03M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $212.12M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $276.19M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $18.83M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |